Ophthalmology
Eysuvis Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Eysuvis® (loteprednol etabonate ophthalmic suspension 0.25%).
Eysuvis® (loteprednol etabonate ophthalmic suspension) is a corticosteroid eye drop indicated for the short-term treatment of the signs and symptoms of dry eye disease. It is administered topically to the eye and may be prescribed during episodes of dry eye flare-ups. Eysuvis® is designed to help manage ocular inflammation associated with dry eye disease.
Built to help reduce friction around treatment access & patient care.
Request Eysuvis® (loteprednol etabonate ophthalmic suspension 0.25%) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Eysuvis Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Eysuvis is a prescription ophthalmic corticosteroid suspension formulated for short-term treatment of dry eye disease signs and symptoms.
Eysuvis may be prescribed for short-term treatment of signs and symptoms of dry eye disease.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.